← Market pulse● Neutral for Indian equitiesRegeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial1 source · first seen 04:00 1 Oct · updated 04:00 1 OctTags on this storyPick a tag to see all its storiesPharma and healthcare7 todayNovo Nordisk1 todayRead the reports1 report · earliest 04:00ReutersRegeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial04:00